| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |